Literature DB >> 16506036

Thirty-eight years of stone meetings in Europe.

K H Bichler1.   

Abstract

Of decisive importance for the many research groups all over Europe were the scientific symposia dealing with the theoretical foundations and clinical aspects of urinary stone disease. There were several sources from which today's European Urinary Stone meetings and the "Eurolithiasis Society" itself arose. It was a long way from Leeds in 1968 to Jena 1970, Bonn-Vienna in 1972 and to 11 European meetings from 1989 to 2005. Which developments in urinary stone disease research have been presented at our congresses during the past 40 years? The 1970s and 1980s are the years marked by efforts to measure the important lithogenic substances such as calcium, ionized calcium, uric acid, phosphate, oxalate with reliable methods. Hypercalciuria and specifically mild hyperoxaluria were the topics of numerous investigations in the 1970s, 1980s and 1990s. The calcium-loading test described by Pak has been discussed frequently since its application. It became apparent that oxalic acid is more important in urinary stone formation than hypercalciuria. Of importance were investigations done by Robertson and his colleagues on the influence of diet (in particular, an animal protein-rich diet) on urinary stone formation. Another emphasis of research was investigation of the crystallization process: supersaturation, crystal growth and aggregation are important steps in urinary stone formation. Of great importance in the formation of urinary stones are inhibitors (inhibitory activity): citrate, magnesium, pyrophosphate, macromolecules: GAGs, THP etc. and it became possible in the early 1970s to determine substances such as Tamm-Horsfall protein (THP) and GAGs. Much attention in the 1970s and 1980s was focused on urinary stone analysis (X-ray diffraction, infrared spectroscopy, polarization microscopy) and standardization of these methods. In the mid-1980s, a whole series of epidemiological studies were carried out, with data for the Federal Republic of Germany, East Germany, Czechoslovakia and Austria. The search for "stone-removing" medications, their description and clinical use was the subject of much clinical research and in vitro examinations. A definite advance occurred in the 1980s with the development of new instrumental technologies for the management of urinary stones such as shockwave ("Stosswelle") lithotripsy, percutaneous nephrolithotomy and ureterorenoscopy (" breakthrough innovations"). Since the 8th European Urolithiasis Symposium there have regularly been presentations pertaining to the topic of the molecular basis of inherited lithiasis. The last 10-15 years have shown an increasing turning toward the importance of cellular alterations and supersaturation and their relation to stone formation. In conclusion, I would like to note that it is of decisive importance for the research groups all over Europe to organize scientific symposia dealing with the theoretical foundations and clinical aspects of urinary stone disease under the protection of the European Urolithiasis Society.

Entities:  

Mesh:

Year:  2006        PMID: 16506036     DOI: 10.1007/s00240-005-0013-5

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  7 in total

1.  Uromucoid excretion of normal individuals and stone formers.

Authors:  K H Bichler; C Kirchner; V Ideler
Journal:  Br J Urol       Date:  1975

2.  Ureterorenoscopy in the treatment of ureteral stones.

Authors:  K H Bichler; S Halim
Journal:  Urol Int       Date:  1986       Impact factor: 2.089

3.  A simplified and rapid enzymatic method for determination of urinary oxalate.

Authors:  P C Hallson; G A Rose
Journal:  Clin Chim Acta       Date:  1974-08-30       Impact factor: 3.786

4.  [Percutaneous nephrolithotomy].

Authors:  P Alken
Journal:  Urologe A       Date:  1984-01       Impact factor: 0.639

5.  Human uromucoid. I. Quantitative immunoassay.

Authors:  K H Bichler; H Haupt; G Uhlemann; H G Schwick
Journal:  Urol Res       Date:  1973-05

6.  Determination of the calcium oxalate crystallization risk from urine samples: the BONN Risk Index in comparison to other risk formulas.

Authors:  Norbert Laube; Stefan Hergarten; Bernd Hoppe; Matthias Schmidt; Albrecht Hesse
Journal:  J Urol       Date:  2004-07       Impact factor: 7.450

7.  Epidemiology, Pathogenesis and diagnosis of calcium oxalate urolithiasis.

Authors:  E W Vahlensieck; D Bach; A Hesse; A Strenge
Journal:  Int Urol Nephrol       Date:  1982       Impact factor: 2.370

  7 in total
  1 in total

Review 1.  [Urinary calculi. Metabolism and diagnosis].

Authors:  R E Hautmann; M Straub
Journal:  Urologe A       Date:  2006-09       Impact factor: 0.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.